Tissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profiles

Clinical Biochemistry

Volumn 40, Issue 3-4, 2007, Pages 278-281

  Rodriguez, Javier ^a,b   Varela Calviño, Rubén ^a   Garrido Outeiriño, Manuel ^a,b   Rodríguez Segade, Santiago ^a,b   Camiña, Felix ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

Clinical complications; Diabetes mellitus; Proliferative marker; Tissue polypeptide specific antigen (TPS)

Indexed keywords

BIOCHEMICAL MARKER; TISSUE POLYPEPTIDE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCHOOL CHILD; TISSUE LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PEPTIDES;

EID: 33846219148     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.11.006     Document Type: Article

References (15)

1. Rydlander L., Ziegler E., Bergman T., et al. Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur. J. Biochem. 241 (1996) 309-314
2. Giovagnoli M.R., Valli C., and Vecchione A. Immunohistochemical expression of tissue polypeptide specific (TPS) antigen in normal and neoplastic tissues. Anticancer Res. 14 (1994) 635-641
3. Harlozinska A., Sedlaczek P., Van Dalen A., Rozdolski K., and Einarsson R. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms. Anticancer Res. 17 (1997) 4473-4478
4. Duffy M.J., van Dalen A., Haglund C., et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur. J. Cancer 39 (2003) 718-727
5. Kassanos D., Botsis D., Rizos D., Kontoravdis A., Sikiotis K., Phocas I., et al. Tissue polypeptide specific antigen (TPS) throughout normal pregnancy. Anticancer Res. 20 (2000) 2129-2131
6. Gonzalez-Quintela A., Mella C., Perez L.F., Abdulkader I., Caparrini A.M., and Lojo S. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis. Alcohol.: Clin. Exp. Res. 24 (2000) 1222-1226
7. Tramonti G., Ferdeghini M., Donadio C., et al. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia. Cancer Detect. Prev. 24 (2000) 86-90
8. Nagele H., Bahlo M., Klapdor R., and Rodiger W. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation. Anticancer Res. 19 (1999) 2531-2534
9. Malamitsi-Puchner A., Vazeou-Gerasimidi A., Sarandakou A., Tziotis J., Trikka P., and Bartsocas C.S. Tissue polypeptide-specific antigen serum concentrations in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 25 (2002) 240-241
10. Kashiwabara K., Nakamura H., Kiguchi T., and Matsuoka T. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases. Clin. Chim. Acta 273 (1998) 35-42
11. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
12. Rodriguez-Segade S., Camina M.F., Carnero A., et al. High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications. Clin. Chem. 42 (1996) 1064-1067
13. Rodriguez-Segade S., Camina M.F., Paz J.M., and Del Rio R. Abnormal serum immunoglobulin concentrations in patients with diabetes mellitus. Clin. Chim. Acta 203 (1991) 135-142
14. Zatloukal K., Stumptner C., Lehner M., et al. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am. J. Pathol. 156 (2000) 1263-1274
15. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 27 (2004) S79-S83